Big Molecule Watch
- Samsung and Regeneron Settle Aflibercept BPCIA Case February 13, 2026 Riley Wyberg
- Reforms to FDA Requirements for Cell and Gene Therapy Products February 12, 2026 Natasha Daughtrey
- Hikma Launches Denosumab Biosimilars ENOBY and XTRENBO February 10, 2026 Christopher Cassella
- Genentech/Hoffmann La-Roche and Shanghai Henlius Biotech/Organon Settle Pertuzumab BPCIA Case February 5, 2026 Christopher Cassella
- European Biologic and Biosimilar Updates February 5, 2026 Emma Murray
- FDA Issues Guidance on Modernizing Statistical Methods for Clinical Trials February 4, 2026 Riley Wyberg
- AbbVie and Novartis Announce Billion Dollar Licensing Deals for Oncology and Alzheimer’s Treatments January 27, 2026 Tara Thigpen
- Year in Review: Top Legal Developments of 2025 January 21, 2026 Tara Thigpen|Riley Wyberg|Sam Herron
- Year in Review: Big Deals of 2025 January 13, 2026 Timothy Beavers|Yoko Bian
- Celltrion and Sandoz Launch Their Aflibercept Biosimilars in Europe January 6, 2026 Allegra Padula